Temporal kinetics and cellular phenotype of TNF p55/p75 receptors in experimental allergic encephalomyelitis

Journal of Neuroimmunology

Volumn 95, Issue 1-2, 1999, Pages 19-34

  Kahn, M A ^a   Dopp, J M ^a   Liva, S ^a   MacKenzie Graham, A J ^b   Chang, R ^a   Huang, A ^a   Nazarian, R ^a   Dell'Albani, P ^c   Condorelli, D ^c   Voskuhl, R R ^a   De Vellis, J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

EAE; High endothelial venutes; Leukocytes; LT ; TNF receptor; TNF

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; MESSENGER RNA; TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CELL ADHESION; CELL INFILTRATION; DEMYELINATING DISEASE; FEMALE; IMMUNIZATION; IMMUNOPATHOLOGY; INFLAMMATION; INFLAMMATORY CELL; KINETICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ANIMALS; ANTIGENS, CD; AZURE STAINS; BLOTTING, NORTHERN; CHRONIC DISEASE; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION; KINETICS; LYMPH NODES; LYMPHOCYTES; MICE; MICE, INBRED STRAINS; MICROGLIA; MONOCYTES; NEUTROPHILS; PEPTIDYLPROLYL ISOMERASE; PHENOTYPE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECURRENCE; RNA PROBES; RNA, MESSENGER; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0033103349     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00258-6     Document Type: Article

References (75)

1. Anderson A., Anderson N. Lymphocyte emigration from high endothelial venules in rat lymph nodes. Immunology. 31:1976;731-748.
2. Angehrn, P., Banner, D., Braun, T., d'Arcy, A., Gehr, G., Gentz, R., Mackay, F., Schlaeger, E.-J., Schoenfeld, H., Loetscher, H., Lesslauer, W., 1993. Two distinct tumor necrosis factor receptors in health and disease. In: Fiers, W., Buurman, W. (Eds.), Tumor Necrosis Factor: Molecular and Cellular Biology and Clinical Relevance, Karger, Basel, pp. 33-39.
3. Arenzana-Seisdedos A.S.C., Morgensen F., Vuillier F., Fiers W., Virelizier J.L. Autocrine secretion of tumor necrosis factor under the influence of intereron-γ amplifies HLA-DR gene expression in human monocytes. Proc. Natl. Acad. Sci. U.S.A. 86:1988;6087-6091.
4. Baker D., O'Neill J.K., Turk J.L. Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell. Immunol. 134:1991;505-510.
5. Baker D., Butler D., Scallon B.J., O'Neill J.K., Turk J.L., Feldmann M. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24:1994;2040-2048.
6. Barlow C. A study of abnormal blood-brain permeability in experimental allergic encephalomyelitis. J. Neuropathol. Exp. Neurol. 15:1956;196-207.
7. Bebo B., Linthicum S. Expression of mRNA for 55-kDa and 75-kDa tumor necrosis factor (TNF) receptors in mouse cerebrovascular endothelium: effects of interleukin-1β, interferon-γ and TNF-α on cultured cells. J. Neuroimmunol. 62:1995;161-167.
8. Beg A., Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274:1996;782-784.
9. Beutler B., Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature. 320:1986;584-588.
10. Beutler B., van Huffel C. Unraveling function in the TNF ligand and receptor families. Science. 264:1994;667-668.
11. Bonetti B., Raine C.S. Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42:1997;74-84.
12. Cormack, D.H., 1984. Blood cells. In: Burgower, W., Darlene, D., Pedersen J.B. (Eds.), Introduction to Histology, Lippincott, Philadelphia, pp. 121-156.
13. 14C -labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis Lab. Invest. 63:1990;162-170.
14. Denhardt D.T. A membrane-filter technique for the detection of complementary DNA. Biochem. Biophys. Res. Commun. 23:1966;641-646.
15. Dopp J., MacKenzie-Graham A., Otero G., Merrill J. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J. Neuroimmunol. 75:1997;104-112.
16. Eugster H.-P., Muller M., Karrer U., Car B.D., Schnyder B., Eng V.M., Woerly G., Le Hir M., di Padova Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double deficient mice. Int. Immunol. 8:1996;23-36.
17. Fallis R.J., Powers M.L., Sy M.S., Weiner H.L. Adoptive transfer of murine chronic-relapsing autoimmune encephalomyelitis. Analysis of basic protein-reactive cells in lymphoid organs and nervous system of donor recipient animals. J. Neuroimmunol. 14:1987;205-219.
18. Frei K., Eugster H.-P., Bopst M., Constantinescu C.S., Lavi E., Fontana A. Tumor necrosis factor-α and lymphotoxin-α are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1997;2177-2182.
19. Gowans J., Knight E. The route of re-circulation of lymphocytes in the rat. Proc. R. Soc. B. 159:1964;257-282.
20. Gray P.W., Aggarwal B.B., Benton C.V., Bringman T.S., Henzel W.J., Jarrett J.A., Leung D.W., Moffat B., Ng P., Svedersky L.P. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity. Nature. 312:1984;721-724.
21. Grell M., Wajant H., Zimmerman G., Scheurich P. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc. Natl. Acad. Sci. U.S.A. 95:1998;570-575.
22. Hansen L.A., Willenborg D.O., Cowen W.B. Suppression of hyeracute and passively transferred experimental autoimmune encephalomyelitis by the anti-oxidant, butylated hydroxyanisole. J. Neuroimmunol. 62:1995;69-77.
23. Hofman F., Hinton D., Johnson K., Merrill J. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170:1989;607-612.
24. Holmes E., Hermanson G., Cole R., de Vellis J. Developmental expression of glial specific mRNAs in primary cultures of rat brain visualized by in situ hybridization. J. Neurosci. Res. 19:1988;389-396.
25. Huang K., Geoffroy J., Singer M., Rosen S. A lymphocyte homing receptor (L-selectin) mediates the in vitro attachment of lymphocytes to myelinated tracts of the central nervous system. J. Clin. Invest. 88:1991;1778-1783.
26. Hsu H., Shu H., Pan M., Goeddel D. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:1996;299-308.
27. Hughes C., Male D., Lantos P. Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon-γ, tumor necrosis factor, and interleukin-1. Immunology. 64:1988;677-681.
28. Humason, G.L., 1972. Animal Tissue Techniques. In: Kennedy, D., Park, R.B. (Eds.), Staining hematologic elements and related tissues, W.H. Freeman, San Francisco, pp. 256-258.
29. Kahn M.A., Ellison J.A., Chang R.P., Speight G.J., de Vellis J. Intracerebral injections of CNTF induces GFAP in an S100α expressing cell population in the CNS: CNTF-αR expression was restricted to neurons suggesting an indirect mode of action. Dev. Brain Res. 98:1997;221-233.
30. Karin N., Szafer F., Mitchell D., Gold D.P., Steinman L. Selective and nonselective stages in homing of T lymphocytes to the central nervous system during experimental allergic encephalomyelitis. J. Immunol. 150:1993;4116-4124.
31. Korner H., Riminton D.S., Strickland D.H., Lemckert F.A., Pollard J.D., Sedgwick J.D. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1997;1585-1590.
32. Kuchroo V.K., Martin C.A., Greer J.M., Ju S.-T., Sobel R.A., Dorf M.E. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:1993;4371-4382.
33. Kuroda T., Shimamoto Y. Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 34:1991;159-164.
34. Lewis M., Tartaglia L., Lee A., Bennett G., Rice G., Wong G., Hen E., Goeddell D. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate that one receptor is species specific. Proc. Natl. Acad. Sci. U.S.A. 88:1991;2830-2834.
35. Liu J., Marino M.W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A.J., Old L., Bernard C.C. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nature Med. 4:1998;78-83.
36. Louis J.-C., Magal E., Takayama S., Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science. 259:1993;689-692.
37. MacKenzie-Graham A.J., Pribyl T.M., Kim S., Porter V.R., Campagnoni A.T., Voskuhl R.R. Myelin protein expression is increased in lymph nodes of mice with relapsing experimental autoimmune encephalomyelitis. J. Immunol. 159:1997;4602-4610.
38. Male D., Pryce G., Hughes C., Lantos P. Lymphocyte migration into brain modeled in vitro: control by lymphocyte activation, cytokines and antigen. Cell Immunol. 127:1990;1-11.
39. Male D., Pryce G., Rahman J. Comparison of the immunological properties of rat cerebral and aortic endothelium. J. Neuroimmunol. 30:1990;161-168.
40. McFarlin D.E., McFarlin H.F. Multiple sclerosis. New Engl. J. Med. 307:1982;1183-1188.
41. McFarlin D.E., McFarlin H.F. Multiple sclerosis. New Engl. J. Med. 307:1982;1246-1251.
42. McRae B.L., Vanderlugt C.L., Dal Canto M.C., Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:1995;75-85.
43. Merrill J., Kono D., Clayton J., Ando D., Hinton D., Hofman F. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. U.S.A. 89:1992;574-578.
44. Molony L., Armstrong L. Cytoskeletal reorganizations in human umbilical vein endothelial cells as a result of cytokine exposure. Exp. Cell Res. 196:1991;40-48.
45. Ohmann H.B., Campos M., McDougall L., Lawman M.J., Babiuk L.A. Expression of tumor necrosis factor-α receptors on bovine macrophages, lymphocytes and polymorphonuclear leukocytes, internalization of receptor-bound ligand, and some functional effects. Lymphokine Res. 9:1990;43-58.
46. Old, L.J., 1990. Tumor necrosis factor: structure, mechanism of action, role of disease and therapy. In: Bonavida, B., Granger, G. (Eds.), Karger, Basel, pp. 1-30.
47. Osborn L., Hession C., Tizard R., Vassallo C., Luhowskyj S., Chi-Rosso G., Lobb R. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial cell protein that binds to lymphocytes. Cell. 59:1989;1203-1211.
48. Pettinelli C.B., Fritz R.B., Chou Jen C.H., McFarlin D.E. Encephalogenic activity of guinea pig myelin basic protein in the SJL mouse. J. Immunol. 129:1982;1209-1211.
49. Pober J.S., Lapierre L.A., Stolpen A.H., Brock T.A., Springer T.A., Fiers W., Bevilacqua M.P., Mendrick D.L., Gimbrone M.A. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin-1 species. J. Immunol. 138:1987;3319-3324.
50. Powell M.B., Mitchell D., Lederman J., Buckmeier S., Zamvil S., Graham M., Ruddle N.H., Steinman L. Lymphotoxin and tumor necrosis factor-α production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2:1990;539-544.
51. Probert L., Akassoglu K., Kozieradzki I., Pfeffer K., Mak T., Neu N., Penninger J. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. Natl. Acad. Sci. U.S.A. 92:1995;11294-11298.
52. Raine, C.S., 1985. Experimental allergic encephalomyelitis. In: Koetsier, J.C. (Ed.), Handbook of clinical neurology, Vol. 3. Amsterdam, Elsevier, pp. 429-466.
53. Raine C.S. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion. Ann. Neurol. 36:1984;561-572.
54. Renno T., Krakowski M., Piccirillo C., Lin J.-y., Owens T. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. J. Immunol. 154:1995;944-953.
55. Rothe M., Wong S., Henzel W., Goeddel D. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78:1994;681-692.
56. Ruddle N., Bergman C., McGrath K., Lingenheld E., Grunnet M., Padula S., Clark R. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
57. Schütze S., Wiegmann K., Machleidt T., Krönke M. TNF-induced activation of NF-κB. Immunobiology. 193:1995;193-203.
58. Selmaj K., Papierz W., Glabinski A., Kono T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56:1995;135-141.
59. Selmaj K., Raine C., Cross A. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30:1991;694-700.
60. Selmaj K., Raine C., Canella B., Brosnan C. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87:1991;949-954.
61. Selmaj K., Raine C., Farooq M., Norton W., Brosnan C. Cytokine cytotoxicity against oligodendrocytes: apoptosis induced by lymphotoxin. J. Immunol. 147:1991;1522-1529.
62. Sharief M.K., Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. New Engl. J. Med. 325:1991;467-472.
63. Skundric D.S., Kim C., Tse H.Y., Raine C.S. Homing of T cells to the central nervous system throughout the course of relapsing experimental allergic encephalomyelitis in Thy-1 congenic mice. J. Neuroimmunol. 46:1993;113-121.
64. Sobel R., Blanchette B., Bhan A., Colvin R. The immunopathology of experimental allergic encephalomyelitis I: Quantitative analysis of inflammatory cells in situ. J. Immunol. 132:1984;393-2401.
65. Steinman L. Some misconceptions about understanding autoimmunity through experiments with knockouts. J. Exp. Med. 12:1997;2039-2041.
66. Suen W.E., Bergman C.M., Hjelmstrom P., Ruddle N.H. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 186:1997;1233-1240.
67. Sullivan G.W., Gelrud A.K., Carper H.T., Mandell G.L. Interaction of tumor necrosis factor-alpha and granulocyte colony-stimulating factor on neutrophil apoptosis, receptor expression, and bactericidal function. Proc. Natl. Assoc. Phys. 108:1996;455-466.
68. Tartaglia L., Goeddel D. Two TNF receptors. Immunol. Today. 13:1992;151-153.
69. Tartaglia L., Rothe M., Hu Y.-F., Goeddel D. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell. 73:1993;213-216.
70. Tartaglia L., Weber R., Figari I., Reynolds C., Palladino M., Goeddel D. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. U.S.A. 88:1991;9292-9296.
71. Vulpe M., Hawkins A., Rozdilsky B. Permeability of cerebral blood vessels in experimental allergic encephalomyelitis studied by radioactive iodinated bovine albumin. Neurology. 10:1960;171-177.
72. Wilcox J.N. Fundamental principles of in situ hybridization. J. Histochem. Cytochem. 41:1994;1725-1733.
73. Wilt S.G., Milward E., Zhou J.M., Nagasato K., Patton H., Rusten R., Griffin D.E., O'Connor M., Dubois-Dalcq M. In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type 1 encephalopathy. Ann. Neurol. 37:1994;381-394.
74. Yednock T.A., Cannon C., Fritz L., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental allergic encephalomyelitis by antibodies against integrin. Nature. 356:1992;63.
75. Zeman K., Kantorski J., Paleolog E.M., Feldmann M., Tchorzewski H. The role of receptors for tumor necrosis factor-alpha in the induction of human polymorphonuclear neutrophil chemiluminescence. Immunol. Lett. 53:1996;45-50.